Want to join the conversation?
$ABC said its total segment revenue was up 7% and the company's drug company had a growth rate of over 5%. The company noted that its full year 2016 expense is expected to be less than the previous year, primarily due to the slightly lower projected brand inflation rate. $ABC also believes generic price inflation to be modest for the year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?